ICON Change in Accounts Receivable 2010-2025 | ICLR
ICON annual/quarterly change in accounts receivable history and growth rate from 2010 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
- ICON change in accounts receivable for the quarter ending June 30, 2025 was $0.024B, a 87.74% decline year-over-year.
- ICON change in accounts receivable for the twelve months ending June 30, 2025 was $0.736B, a 807.37% decline year-over-year.
- ICON annual change in accounts receivable for 2024 was $0.349B, a 519.36% decline from 2023.
- ICON annual change in accounts receivable for 2023 was $-0.083B, a 80.2% decline from 2022.
- ICON annual change in accounts receivable for 2022 was $-0.421B, a 470.61% decline from 2021.
| ICON Annual Change in Accounts Receivable (Millions of US $) |
|
|---|---|
| 2024 | $349 |
| 2023 | $-83 |
| 2022 | $-421 |
| 2021 | $114 |
| 2020 | $-175 |
| 2019 | $-102 |
| 2018 | $-38 |
| 2017 | $58 |
| 2016 | $3 |
| 2015 | $-19 |
| 2014 | $-7 |
| 2013 | $-38 |
| 2012 | $-79 |
| 2011 | $N/A |
| 2010 | $N/A |
| 2009 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $14.200B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.037B | 28.01 |
| CVS Health (CVS) | United States | $87.007B | 10.82 |
| Elevance Health (ELV) | United States | $69.708B | 9.38 |
| Cencora (COR) | United States | $56.771B | 18.90 |
| DiDi Global (DIDIY) | China | $25.839B | 27.45 |
| Labcorp Holdings (LH) | United States | $22.469B | 17.86 |
| Natera (NTRA) | United States | $22.374B | 0.00 |
| BioMerieux (BMXMF) | France | $17.238B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.627B | 0.00 |
| CochLear (CHEOY) | Australia | $13.374B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.862B | 34.04 |
| Solventum (SOLV) | United States | $12.383B | 12.78 |
| Viatris (VTRS) | United States | $12.370B | 4.40 |
| Revvity (RVTY) | United States | $10.537B | 18.56 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.265B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.104B | 0.00 |
| Avantor (AVTR) | United States | $8.815B | 12.93 |
| HealthEquity (HQY) | United States | $7.773B | 34.05 |
| Charles River Laboratories (CRL) | United States | $7.711B | 14.63 |
| Bausch + Lomb (BLCO) | Canada | $5.151B | 34.64 |
| Sotera Health (SHC) | United States | $4.471B | 24.98 |
| BrightSpring Health Services (BTSG) | United States | $3.975B | 30.32 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.82 |
| GeneDx Holdings (WGS) | United States | $3.630B | 83.13 |
| Alignment Healthcare (ALHC) | United States | $2.980B | 0.00 |
| Concentras Parent (CON) | United States | $2.979B | 18.89 |
| Surgery Partners (SGRY) | United States | $2.923B | 36.77 |
| Organon (OGN) | United States | $2.454B | 2.67 |
| Premier (PINC) | United States | $2.054B | 15.59 |
| Progyny (PGNY) | United States | $2.012B | 42.55 |
| Ardent Health (ARDT) | United States | $1.786B | 6.90 |
| PACS (PACS) | United States | $1.753B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.397B | 9.33 |
| Teladoc Health (TDOC) | United States | $1.329B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.296B | 21.94 |
| Omada Health (OMDA) | $1.182B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.110B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.965B | 0.00 |
| Embecta (EMBC) | United States | $0.801B | 4.69 |
| AMN Healthcare Services Inc (AMN) | United States | $0.725B | 8.97 |
| CareDx (CDNA) | United States | $0.630B | 11.61 |
| Performant Healthcare (PHLT) | United States | $0.601B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.525B | 90.00 |
| Nutex Health (NUTX) | United States | $0.516B | 7.81 |
| Sonida Senior Living (SNDA) | United States | $0.476B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.467B | 10.52 |
| InnovAge Holding (INNV) | United States | $0.463B | 0.00 |
| SBC Medicals (SBC) | United States | $0.462B | 10.14 |
| Agilon Health (AGL) | United States | $0.460B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.414B | 0.00 |
| Enhabit (EHAB) | United States | $0.383B | 25.20 |
| So-Young (SY) | China | $0.379B | 0.00 |
| Oncology Institute (TOI) | United States | $0.336B | 0.00 |
| LifeMD (LFMD) | United States | $0.305B | 0.00 |
| Beauty Health (SKIN) | United States | $0.275B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.215B | 0.00 |
| DocGo (DCGO) | United States | $0.158B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.133B | 0.00 |
| KindlyMD (NAKA) | United States | $0.104B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.085B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| Biodesix (BDSX) | United States | $0.058B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.036B | 0.00 |
| ModivCare (MODV) | United States | $0.034B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |